Sven Frøkjær

9.1k total citations · 3 hit papers
116 papers, 7.4k citations indexed

About

Sven Frøkjær is a scholar working on Molecular Biology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Sven Frøkjær has authored 116 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 24 papers in Oncology and 20 papers in Pharmaceutical Science. Recurrent topics in Sven Frøkjær's work include Drug Transport and Resistance Mechanisms (22 papers), Protein purification and stability (20 papers) and Lipid Membrane Structure and Behavior (19 papers). Sven Frøkjær is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Protein purification and stability (20 papers) and Lipid Membrane Structure and Behavior (19 papers). Sven Frøkjær collaborates with scholars based in Denmark, United States and Netherlands. Sven Frøkjær's co-authors include Daniel E. Otzen, Camilla Foged, Birger Brodin, Jens Brange, Anne Sundblad, Vladimir N. Uversky, Anthony L. Fink, Marco van de Weert, James M. Flink and Sandip B. Vyas and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Biochemistry.

In The Last Decade

Sven Frøkjær

116 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism

2001 1.0k citations Sven Frøkjær, Jens Brange et al. profile →
Protein drug stability: a formulation challenge

2005 896 citations Sven Frøkjær, Daniel E. Otzen Nature Reviews Drug Discovery profile →
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model

2005 698 citations Camilla Foged, Birger Brodin et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven Frøkjær Denmark	41	4.2k	1.3k	1.2k	961	685	116	7.4k
Marco van de Weert Denmark	35	2.9k 0.7×	637 0.5×	1.1k 1.0×	869 0.9×	561 0.8×	97	5.4k
Hidetoshi Arima Japan	44	3.2k 0.7×	367 0.3×	2.2k 1.9×	1.2k 1.3×	570 0.8×	264	7.2k
Sophia G. Antimisiaris Greece	37	2.2k 0.5×	700 0.5×	1.5k 1.3×	1.5k 1.5×	785 1.1×	132	5.3k
Subhash C. Chauhan United States	56	4.6k 1.1×	453 0.3×	769 0.7×	2.2k 2.3×	1.4k 2.0×	181	9.7k
Balaram Ghosh India	50	3.7k 0.9×	995 0.8×	409 0.4×	1.8k 1.9×	1.5k 2.3×	307	9.8k
Carsten Ehrhardt Ireland	43	1.7k 0.4×	514 0.4×	986 0.9×	739 0.8×	949 1.4×	136	5.6k
Gert Fricker Germany	56	3.3k 0.8×	631 0.5×	2.1k 1.8×	1.3k 1.3×	614 0.9×	258	10.6k
Caitríona M. O’Driscoll Ireland	49	3.3k 0.8×	275 0.2×	1.7k 1.5×	1.5k 1.5×	1.1k 1.5×	131	7.0k
Giovanni Tosi Italy	42	2.0k 0.5×	607 0.5×	1.1k 0.9×	2.2k 2.3×	1.3k 1.9×	203	6.0k
Patrick Garidel Germany	54	4.8k 1.1×	273 0.2×	813 0.7×	460 0.5×	893 1.3×	184	7.5k

Countries citing papers authored by Sven Frøkjær

Since Specialization

Citations

This map shows the geographic impact of Sven Frøkjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Frøkjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Frøkjær more than expected).

Fields of papers citing papers by Sven Frøkjær

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Frøkjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Frøkjær. The network helps show where Sven Frøkjær may publish in the future.

Co-authorship network of co-authors of Sven Frøkjær

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Frøkjær. A scholar is included among the top collaborators of Sven Frøkjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Frøkjær. Sven Frøkjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sachs, M., et al.. (2019). Danish Physicians’ Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study. Pharmaceutical Medicine. 33(2). 99–107. 1 indexed citations

Sachs, M., et al.. (2017). Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions. Pharmaceutical Medicine. 31(4). 245–255. 12 indexed citations

Knudsen, Nina Østergaard, Raymond M. Schiffelers, Lene Jørgensen, et al.. (2012). Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α2β1 receptor. International Journal of Pharmaceutics. 428(1-2). 171–177. 16 indexed citations

Groenning, Minna, Mathias Norrman, James M. Flink, et al.. (2007). Binding mode of Thioflavin T in insulin amyloid fibrils. Journal of Structural Biology. 159(3). 483–497. 191 indexed citations

Foged, Camilla, Hanne Mørck Nielsen, & Sven Frøkjær. (2007). Phospholipase A₂Sensitive Liposomes for Delivery of Small Interfering RNA (siRNA). Journal of Liposome Research. 17(3-4). 191–196. 14 indexed citations

Foged, Camilla, Hanne Mørck Nielsen, & Sven Frøkjær. (2006). Liposomes for phospholipase A2 triggered siRNA release: Preparation and in vitro test. International Journal of Pharmaceutics. 331(2). 160–166. 43 indexed citations

Jørgensen, Flemming Steen, et al.. (2006). Computational prediction of solubilizers’ effect on partitioning. International Journal of Pharmaceutics. 329(1-2). 46–52. 4 indexed citations

Jørgensen, Lene, Eva Horn Moeller, Marco van de Weert, Hanne Mørck Nielsen, & Sven Frøkjær. (2006). Preparing and evaluating delivery systems for proteins. European Journal of Pharmaceutical Sciences. 29(3-4). 174–182. 59 indexed citations

Jørgensen, Lene, et al.. (2005). Interfacial adsorption of insulin. European Journal of Pharmaceutical Sciences. 27(2-3). 194–204. 70 indexed citations

10.

Frøkjær, Sven & Daniel E. Otzen. (2005). Protein drug stability: a formulation challenge. Nature Reviews Drug Discovery. 4(4). 298–306. 896 indexed citations breakdown →

11.

Nielsen, Carsten Uhd, Jan Amstrup, R. Nielsen, et al.. (2003). Epidermal growth factor and insulin short‐term increase hPepT1‐mediated glycylsarcosine uptake in Caco‐2 cells. Acta Physiologica Scandinavica. 178(2). 139–148. 23 indexed citations

12.

Uversky, Vladimir N., Ian S. Millett, Sven Frøkjær, et al.. (2003). Prediction of the association state of insulin using spectral parameters. Journal of Pharmaceutical Sciences. 92(4). 847–858. 72 indexed citations

13.

Taub, Mitchell E., et al.. (2002). Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I–IV. European Journal of Pharmaceutical Sciences. 15(4). 331–340. 58 indexed citations

14.

Christensen, Inge Thøger, et al.. (1999). Structure−Property Model for Membrane Partitioning of Oligopeptides. Journal of Medicinal Chemistry. 43(1). 103–113. 33 indexed citations

15.

Christensen, Inge Thøger, et al.. (1998). Predicting Drug Absorption from Molecular Surface Properties Based on Molecular Dynamics Simulations. Pharmaceutical Research. 15(7). 972–978. 64 indexed citations

16.

Jones, LaToya S., Theodore W. Randolph, Sven Frøkjær, et al.. (1998). Effect of tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. Journal of Pharmaceutical Sciences. 87(12). 1597–1603. 194 indexed citations

17.

BRØNDSTED, H.V., et al.. (1996). Fat Emulsions Based on Structured Lipids (1,3-specific triglycerides): An Investigation of the in Vivo Fate. Pharmaceutical Research. 13(5). 725–728. 20 indexed citations

18.

Frøkjær, Sven. (1994). Use of hydrosylates for protein supplementation. Food technology. 48(10). 86–88. 104 indexed citations

19.

Ovesen, Lars, et al.. (1991). Bacterial contamination and growth in two defined formula diets of different pH. Clinical Nutrition. 10(2). 114–119. 7 indexed citations

20.

Nielsen, Mogens Brøndsted, Sven Frøkjær, & C. Bræstrup. (1988). High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochemical Pharmacology. 37(17). 3285–3287. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact